Timothy J. Vanderkwaak

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Robert L. Coleman, Amit M. Oza, Domenica Lorusso et al. · The Lancet · 2017 · 1.7K citations · Full text

Medicine, Gynecology, Oncology +12

An Advanced Generation of Adenoviral Vectors Selectively Enhances Gene Transfer for Ovarian Cancer Gene Therapy Approaches

Timothy J. Vanderkwaak, Minghui Wang, Jesús Gómez-Navarro et al. · Gynecologic Oncology · 1999 · 116 citations

Pharmacy, Biotechnology, Oncology +14

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 86 citations · Full text

Medicine, Gynecology, Oncology +11

Factors influencing pregnancy outcome after trauma.

George Er, Timothy J. Vanderkwaak, Scholten Dj · PubMed · 1992 · 27 citations

Medicine, Maternal Health, Obstetrics +17

Detection of Coxsackie–Adenovirus Receptor (CAR) Immunoreactivity in Ovarian Tumors of Epithelial Derivation

Hanh Khuu, Michael Conner, Timothy J. Vanderkwaak et al. · Applied immunohistochemistry & molecular morphology · 1999 · 21 citations

Medicine, Gynecology, Oncology +17